EZACTRIS Trademark

Trademark Overview

On Monday, March 26, 2012, a trademark application was filed for EZACTRIS with the United States Patent and Trademark Office. The USPTO has given the EZACTRIS trademark a serial number of 79115742. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Saturday, March 26, 2022. This trademark is owned by H. Lundbeck A/S. The EZACTRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes
ezactris

General Information

Serial Number79115742
Word MarkEZACTRIS
Filing DateMonday, March 26, 2012
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateSaturday, March 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, September 25, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Tuesday, October 25, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, October 24, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, October 10, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 25, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 25, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 25, 2013ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Wednesday, September 25, 2013ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, September 25, 2013OPPOSITION TERMINATED NO. 999999
Wednesday, September 25, 2013OPPOSITION SUSTAINED NO. 999999
Tuesday, April 16, 2013REFUSAL PROCESSED BY IB
Wednesday, March 20, 2013OPPOSITION INSTITUTED NO. 999999
Tuesday, March 19, 2013OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Tuesday, March 19, 2013OPPOSITION NOTICE (IB REFUSAL) CREATED
Friday, February 8, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 18, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 27, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 22, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 19, 2012ASSIGNED TO LIE
Friday, October 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 5, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 4, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 4, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 15, 2012REFUSAL PROCESSED BY IB
Monday, August 27, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 27, 2012REFUSAL PROCESSED BY MPU
Saturday, August 25, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 24, 2012NON-FINAL ACTION WRITTEN
Tuesday, August 21, 2012APPLICATION FILING RECEIPT MAILED
Friday, August 17, 2012ASSIGNED TO EXAMINER
Friday, August 17, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 16, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 16, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ezactris substances pharmaceutical preparations nervous system disease central treatment prevention disorders